KYMR SG&A Expense Growth

Kymera Therapeutics Inc · SG&A Expense Growth

KYMR logo

KYMR SG&A Expense Growth

Latest reported7.34%
KYMR FY SG&A Growth (YoY) (0.00% → 7.34%)
High-resolution chart · PNG

KYMR sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
7.3441%
15.4303%
25.5669%
20.6053%
99.3364%
128.4551%
111.5854%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.